Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine

Article

Abstract: Extension of the interval between vaccine doses for the BNT162b2 mRNA vaccine was introduced in the

Palabras claves:

antibody, B cell, BNT162b2, covid-19, dosing interval, Neutralization, SARS-CoV-2, T cell, Vaccine, variants of concern

Autores:

Abuelgasim H., Adele S., Adland E., Adlou S., Akther H.D., Al-Taei S., Alhussni A., Ali M., Altmann T., Amini A., Andrew Cross, Angyal A., Arancibia-Cárcamo C.V., Austin J.A., Azim Ansari M., Barnes E., Bayley M., Bridges-Webb A., Brown A., Brown H., Brown R., Carroll M.W., Chalk J., Chand M., Chawla A., Chinnakannan S., Chris Jones, Conlon C.P., Cross A., Cutteridge J., de Lara C., de Silva T.I., Deeks A.S., Dejnirattisai W., Denly L., Diffey B., Dimitriadis S., Dobson S.L., Dold C., Donnison T., Drake T.M., Dunachie S.J., Duncan C.J.A., Dupont M., Eyre D.W., Fairman A., Faustini S., Foulkes S., Frater J., Gardiner S., Gillson N., Goulder P., Hackstein C.P., Hall V., Hambleton S., Haniffa M., Hargreaves A., Haworth J., Hering L.M., Holmes J., Hopkins S., Horner E., Hornsby H., Jämsén A., Javier Gilbert Jaramillo, Jeffery K., Jennifer Holmes, Jenny Haworth, John Frater, Johnson S.A., Jones C., Kasanyinga M., Kelly S., Kilby J.A., Kirk R., Klenerman P., Knight M.L., Lawrie A., Lee L., Lian Lee, Linder A., Longet S., Maeva Dupont, Malone T., Matthews P.C., Meardon N., Mongkolsapaya J., Moore S.C., Nicols A.R., Payne R.P., Phillips E., Pollard A.J., Rebecca Brown, Reyes L.S., Richter A., Rowland-Jones S.L., Saei A., Sandhar G., Screaton G.R., Shields A., Sinead Kelly, Skelly D.T., Stafford L., Supasa P., Thomas Altmann, Tipton T., Turtle L., Tyerman J.K., Whitham R., Wootton D.G.

Fuentes:

scopus